Mercer Global Advisors
NMTR

Mercer Global Advisors’s 9 Meters Biopharma NMTR Stock Holding History

Mercer Global Advisors’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-10,250
Closed -$14K – 2074
2023
Q1 		$14K Buy
+10,250
New +$19.3K ﹤0.01% 1910
2022
Q3 		– Sell
-3,000
Closed -$16K – 1937
2022
Q2 		$16K Hold
3,000
– – ﹤0.01% 1805
2022
Q1 		$36K Hold
3,000
– – ﹤0.01% 1843
2021
Q4 		$59K Hold
3,000
– – ﹤0.01% 1747
2021
Q3 		$78K Buy
+3,000
New +$70.7K ﹤0.01% 1699

Other funds holding NMTR

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ODFS
O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
CIBC Asset Management
CIBC Asset Management Toronto, Ontario, Canada $40.9B AUM 35.96% 1-Year Est. Return

Mercer Global Advisors's NMTR Position: Q2 2023 in Review

Mercer Global Advisors sold out of 9 Meters Biopharma (NMTR) in Q2 2023, closing a stake of 10,250 shares — an estimated $14K sold.

Mercer Global Advisors first reported a position in NMTR in Q3 2021 and held it in 5 quarters. The position peaked at $78K in Q3 2021. 34 funds tracked by Wall St. Rank hold NMTR as of Q2 2023.

  • Mercer Global Advisors reported no remaining 9 Meters Biopharma position as of Q2 2023 after selling out during the quarter.
  • Mercer Global Advisors sold 10,250 9 Meters Biopharma shares in Q2 2023, an estimated $14K.
  • Mercer Global Advisors first reported a position in 9 Meters Biopharma in Q3 2021 and held it in 5 quarters.
  • Mercer Global Advisors's 9 Meters Biopharma position peaked at $78K in Q3 2021.
  • 34 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q2 2023.

Based on Mercer Global Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.